Inside the research
Concentra Group Holdings Parent, Inc.
CON Research profile · latest available data
Price overview
$35.01
▲ +0.39 (+1.1%)
| 52w hi | $36.37 |
|---|---|
| 52w lo | $18.52 |
| Vol | 571.40K |
| As of | 25 Sep 2026 |
The Verdict
Our score +0.52
| Short | +0.39 |
|---|---|
| Medium | +0.64 |
| Long | +0.51 |
computed 2026-09-27
Key fundamentals
Concentra Group Holdings Parent, Inc.
Healthcare · Medical Care Facilities
| Market cap | $4.46B |
|---|---|
| Enterprise value | $6.48B |
| Trailing P/E | 22.59x |
| Forward P/E | 19.01x |
| EV / EBITDA | 14.04x |
| P / S (ttm) | 1.95x |
| Profit margin | 8.7% |
| Return on equity | 47.1% |
| Revenue growth | +10.0% |
| Earnings growth | +47.0% |
| Debt / equity | 423.32 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.29 | |
| Sector | +0.08 | |
| Technical | +0.33 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-09-27
Business overview
Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company operates in three segments: Occupational Health centers, Onsite health clinics, and Other business. It offers occupational health services, including workers compensation, employer, and consumer health services; and employer-sponsored primary care services at workplace, including mobile health and episodic specialty testing services. It also operates Concentra Telemed, a telemedicine platform for the treatment of work-related injuries and illnesses; Concentra Pharmacy for distributing repackaged medications; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. In addition, the company provides injury care, primary care, urgent care, preventive care, clinical testing, physical examinations and evaluations, drug and alcohol screenings, clinical testing, vaccinations and other preventive care, and a range of consultative services designed to protect employees from workplace hazards. The company was founded in 1979 and is based in Addison, Texas.
Risk Metrics
| Beta vs SPX | 0.69 |
|---|---|
| Corr SPX | 0.37 |
| Annual vol | 30.3% |
| Annual ret | +25.9% |
| Sharpe | 0.85 |
| Max DD | -21.4% |
Window: 504 trading days (504 obs)
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-08-06 | Earnings Release, Officer / Director Change… | read |
| 2026-07-10 | Officer / Director Change, Exhibits | read |
| 2026-05-07 | Earnings Release, Reg FD Disclosure… | read |
| 2026-04-30 | Shareholder Vote | read |
| 2026-04-14 | Officer / Director Change, Reg FD Disclosure… | read |
| 2026-02-26 | Earnings Release, Reg FD Disclosure… | read |
| 2026-01-28 | Earnings Release, Reg FD Disclosure… | read |
| 2026-01-12 | Earnings Release, Reg FD Disclosure… | read |
| 2025-11-10 | Officer / Director Change | read |
| 2025-11-06 | Earnings Release, Reg FD Disclosure… | read |
| 2025-08-07 | Earnings Release, Reg FD Disclosure… | read |
| 2025-06-26 | Officer / Director Change, Reg FD Disclosure… | read |
Insider Trades
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-03 | ORTENZIO ROBERT A | Sell | 130.00K | $4.14M | |
| 2026-07-01 | ORTENZIO ROBERT A | Sell | 130.00K | $3.96M | |
| 2026-06-01 | ORTENZIO ROBERT A | Sell | 130.00K | $3.25M | |
| 2026-05-08 | ORTENZIO ROBERT A | Sell | 130.00K | $3.25M | |
| 2025-12-17 | Newton William Keith | Chief Executive Officer | Gift | 89.08K | — |
| 2025-11-26 | Ryan Timothy F. | See Remarks | Withheld for tax | 5.90K | $124.20K |
| 2025-11-26 | Rhine Michael D. | See Remarks | Withheld for tax | 3.94K | $82.79K |
| 2025-11-26 | Nelson Su Zan | See Remarks | Withheld for tax | 5.90K | $124.20K |
| 2025-11-26 | McAndrew Douglas R. | See Remarks | Withheld for tax | 5.90K | $124.20K |
| 2025-11-26 | Kosuth Michael A. | See Remarks | Withheld for tax | 6.45K | $135.69K |
Flow & Concentration
| Insider 180d net | -$14.60M |
|---|---|
| Insider buys / sells | 0 / 4 |
| Insider bias | Sellers |
| 13F holders | 0 |
| Top-5 share | 0.0% |
| HHI | 0 (—) |
SEC Filings
The Long Run
FY 2024–2025 · 2 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $1.84B | -3.3% | |
| Operating income | $333.99M | +9.6% | |
| Net income | $179.95M | +0.0% | |
| Cash from ops | $234.32M | -14.6% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $34.32 | $35.07 | $34.32 | $35.01 | 571.40K |
| Sep 24 | $34.61 | $35.20 | $34.41 | $34.62 | 841.40K |
| Sep 23 | $34.85 | $35.22 | $34.54 | $34.79 | 815.40K |
| Sep 22 | $34.48 | $35.44 | $34.48 | $34.88 | 681.30K |
| Sep 21 | $35.31 | $35.51 | $34.59 | $34.77 | 743.20K |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →